Five children see HIV viral loads vanish after taking antiretroviral drugs

In a groundbreaking study, researchers have discovered that five children with HIV have demonstrated astonishing health improvements after discontinuing their antiretroviral therapy. This intriguing development comes from the work of Philip Goulder, a pediatrician and immunologist at the University of Oxford, who has long pondered whether children might provide critical insights in the search for an HIV cure. Beginning in the mid-2010s, Goulder collaborated with scientists in KwaZulu-Natal, South Africa, to monitor several hundred children who contracted HIV from their mothers during pregnancy, childbirth, or breastfeeding. The aim was to track their health while they received early treatment with antiretroviral drugs, which are designed to prevent the virus from replicating. Over the span of a decade, an unexpected phenomenon occurred. Five of the children stopped visiting the clinic for their medication, and when researchers managed to locate them months later, they were in excellent health. Goulder noted, “Instead of their viral loads being through the roof, they were undetectable.” Typically, HIV levels rebound quickly in patients who stop treatment, but these children defied the norm. In a study published last year, Goulder revealed that all five remained in remission despite not having received regular antiretroviral therapy for extended periods, with one child going as long as 17 months without treatment. This finding suggests a potential breakthrough in the quest for an HIV cure, hinting that the first successful treatments may emerge from pediatric populations rather than adults. At the recent International AIDS Society conference in Kigali, Rwanda, pediatrician Alfredo Tagarro from the Infanta Sofia University Hospital in Madrid contributed further evidence to this theory. He presented new research indicating that about 5 percent of HIV-infected children who start antiretroviral treatment within the first six months of life can suppress the viral reservoir to negligible levels. Tagarro emphasized, “Children have special immunological features which make it more likely that we will develop an HIV cure for them before other populations.”